96 related articles for article (PubMed ID: 31092440)
1. Prognostic Impact of Proximal
Berner K; Bruland ØS
Anticancer Res; 2019 May; 39(5):2459-2466. PubMed ID: 31092440
[TBL] [Abstract][Full Text] [Related]
2. Proximal location in extremity long bones is a poor prognostic factor for osteosarcoma: A retrospective cohort study of 153 patients.
Cates JM; Schoenecker JG
Acta Oncol; 2016 Aug; 55(8):1036-9. PubMed ID: 27145235
[TBL] [Abstract][Full Text] [Related]
3. The extremity localized classic osteosarcomas have better survival than the axial non-classics.
Lin L; Deng S; Zhang F; Liang Y; Huang Z
World J Surg Oncol; 2018 Feb; 16(1):39. PubMed ID: 29471883
[TBL] [Abstract][Full Text] [Related]
4. Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients.
Kelley LM; Schlegel M; Hecker-Nolting S; Kevric M; Haller B; Rössig C; Reichardt P; Kager L; Kühne T; Gosheger G; Windhager R; Specht K; Rechl H; Tunn PU; Baumhoer D; Wirth T; Werner M; von Kalle T; Nathrath M; Burdach S; Bielack S; von Lüttichau I
J Clin Oncol; 2020 Mar; 38(8):823-833. PubMed ID: 31928458
[TBL] [Abstract][Full Text] [Related]
5. Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma.
Berner K; Johannesen TB; Berner A; Haugland HK; Bjerkehagen B; Bøhler PJ; Bruland ØS
Acta Oncol; 2015 Jan; 54(1):25-33. PubMed ID: 24957555
[TBL] [Abstract][Full Text] [Related]
6. Differential presentations, clinical courses, and survivals of osteosarcomas of the proximal humerus over other extremity locations.
Cho WH; Song WS; Jeon DG; Kong CB; Kim MS; Lee JA; Yoo JY; Kim JD; Lee SY
Ann Surg Oncol; 2010 Mar; 17(3):702-8. PubMed ID: 19921336
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic features and prognosis of osteosarcoma in Turkish adults.
Seker MM; Seker A; Aksoy S; Ozdemir N; Uncu D; Zengin N
Asian Pac J Cancer Prev; 2014; 15(8):3537-40. PubMed ID: 24870753
[TBL] [Abstract][Full Text] [Related]
9. Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
Fukushima T; Ogura K; Akiyama T; Takeshita K; Kawai A
BMC Musculoskelet Disord; 2018 Aug; 19(1):297. PubMed ID: 30121085
[TBL] [Abstract][Full Text] [Related]
10. Nonmetastatic osteosarcoma of the extremity. Neoadjuvant chemotherapy with methotrexate, cisplatin, doxorubicin and ifosfamide. An Italian Sarcoma Group study (ISG/OS-Oss).
Ferrari S; Meazza C; Palmerini E; Tamburini A; Fagioli F; Cozza R; Ferraresi V; Bisogno G; Mascarin M; Cefalo G; Manfrini M; Capanna R; Biagini R; Donati D; Picci P
Tumori; 2014; 100(6):612-9. PubMed ID: 25688494
[TBL] [Abstract][Full Text] [Related]
11. Elevated expression of AKT2 correlates with disease severity and poor prognosis in human osteosarcoma.
Zhu Y; Zhou J; Ji Y; Yu B
Mol Med Rep; 2014 Aug; 10(2):737-42. PubMed ID: 24919955
[TBL] [Abstract][Full Text] [Related]
12. [Classical osteosarcoma in children and adolescent].
Rogozhin DV; Bulycheva IV; Konovalov DM; Talalaev AG; Roshchin VY; Ektova AP; Bogoroditsky YS; Strykov VA; Kazakova AN; Olshanskaya YV; Kachanov DY; Tereshchenko GV
Arkh Patol; 2015; 77(5):68-74. PubMed ID: 27077157
[TBL] [Abstract][Full Text] [Related]
13. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of prognostic factors in osteosarcoma adult patients, a single institution experience].
Adamkova Krakorova D; Vesely K; Zambo I; Tucek S; Tomasek J; Jureckova A; Janicek P; Cerny J; Pazourek L; Ondrusek S; Selingerova I
Klin Onkol; 2012; 25(5):346-58. PubMed ID: 23102196
[TBL] [Abstract][Full Text] [Related]
15. The epidemiology of osteosarcoma.
Ottaviani G; Jaffe N
Cancer Treat Res; 2009; 152():3-13. PubMed ID: 20213383
[TBL] [Abstract][Full Text] [Related]
16. Postmetastasis survival in high-grade extremity osteosarcoma: A retrospective analysis of prognostic factors in 126 patients.
Kim W; Han I; Lee JS; Cho HS; Park JW; Kim HS
J Surg Oncol; 2018 May; 117(6):1223-1231. PubMed ID: 29409122
[TBL] [Abstract][Full Text] [Related]
17. Pathologic fracture does not influence local recurrence and survival in high-grade extremity osteosarcoma with adequate surgical margins.
Xie L; Guo W; Li Y; Ji T; Sun X
J Surg Oncol; 2012 Dec; 106(7):820-5. PubMed ID: 22740310
[TBL] [Abstract][Full Text] [Related]
18. [Survival analysis and the effects of prognostic factors in patients treated for osteosarcoma].
Ozger H; Eralp L; Atalar AC; Toker B; Ayan I; Kebudi R; Bağbek S; Başaran M; Ağaoğlu F; Dizdar Y; Bilgiç B
Acta Orthop Traumatol Turc; 2007; 41(3):211-9. PubMed ID: 17876121
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic significance of S100A4 expression in osteosarcoma.
Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
[TBL] [Abstract][Full Text] [Related]
20. [Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].
Zhang Q; Niu XH; Cai YB; Hao L; Ding Y
Zhonghua Wai Ke Za Zhi; 2007 Aug; 45(16):1114-7. PubMed ID: 18005614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]